American Society of Addiction Medicine
American Society of Addiction Medicine
Medicaid Unwinding: Association With New and Ending Buprenorphine Treatment Episodes
Medicaid Unwinding: Association With New and Ending Buprenorphine Treatment Episodes
Medicaid Unwinding: Association With New and Ending Buprenorphine Treatment Episodes
Thursday 11th December 2025
Dr. Bradley Stein discusses Medicaid unwinding's impact on buprenorphine treatment and future research directions in addiction medicine.
16 minutes
Informative
Inspiring
Educational
Hopeful
Engaging
About this podcast
Author:
American Society of Addiction Medicine
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Family Recovery from Addiction
Navigating Intimate Relationships
Nutritional Pathways to Recovery
Links:
Visit site
Episodes:
49 (View all)
Do you want to link to this podcast?
Get the buttons here!Medicaid Unwinding: The Ripple Effect on Addiction Treatment
Episode Overview
- Medicaid unwinding affects buprenorphine treatment episodes among enrollees.
- Vulnerable populations face increased challenges due to unstable coverage.
- Future research will explore state policy approaches to Medicaid unwinding.
- Adaptability is crucial for professionals in the evolving field of addiction medicine.
- Technology plays an increasing role in addiction treatment and support.
"You can't be practicing psychiatry without both treating mental health and substance use. They're co-travelers."
What makes addiction medicine such a fascinating field? This episode of 'Addiction Medicine: Beyond the Abstract' brings Dr. Bradley Stein to the forefront, offering an eye-opening discussion on his latest study titled 'Medicaid Unwinding: Association With New and Ending Buprenorphine Treatment Episodes.' Dr. Stein, a seasoned psychiatrist and policy researcher, shares how Medicaid unwinding impacts buprenorphine treatment among Medicaid enrollees, highlighting the ripple effects on other opioid use disorder (OUD) treatments. Dr.
Stein delves into the complexities faced by vulnerable populations, including those with unstable Medicaid coverage and fragmented community resources. His insights reveal how disruptions in care can lead to a snowball effect, exacerbating existing medical conditions. He also touches on the broader implications of Medicaid unwinding on methadone and non-pharmacologic treatments, stressing the need for future research to explore these effects further. The conversation shifts to future research avenues, with Dr.
Stein expressing interest in how different states have attempted to mitigate Medicaid unwinding's impact. This 'national experiment' offers a unique opportunity to learn from various policy approaches. As Dr. Stein reflects on his career, he offers advice to budding addiction medicine professionals: stay adaptable and aware of evolving challenges, such as the shift from agricultural to synthetic substances and the role of technology in treatment.
This episode is a treasure trove of knowledge for anyone interested in addiction medicine and policy research. As you listen, you'll find yourself contemplating the delicate balance between policy, healthcare access, and individual well-being. What strategies could better support those affected by Medicaid unwinding?